Anti-leukemic activity and mechanisms underlying resistance to the novel immunoproteasome inhibitor PR-924

D. Niewerth; J. van Meerloo; G. Jansen; Y.G. Assaraf; T.C. Hendrickx; C.J. Kirk; J.L. Anderl; S. Zweegman; G.J.L. Kaspers; J. Cloos

doi:https://doi.org/10.1016/j.bcp.2014.02.005

Anti-leukemic activity and mechanisms underlying resistance to the novel immunoproteasome inhibitor PR-924

D. Niewerth, J. van Meerloo, G. Jansen, Y.G. Assaraf, T.C. Hendrickx, C.J. Kirk, J.L. Anderl, S. Zweegman, G.J.L. Kaspers, J. Cloos

Research output: Contribution to journal › Article › Academic › peer-review

35 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	43-51
Journal	Biochemical Pharmacology
Volume	89
Issue number	1
DOIs	https://doi.org/10.1016/j.bcp.2014.02.005
Publication status	Published - 2014

Access to Document

https://doi.org/10.1016/j.bcp.2014.02.005

Cite this

@article{d7d28699d61541de808879621a7b940d,

title = "Anti-leukemic activity and mechanisms underlying resistance to the novel immunoproteasome inhibitor PR-924",

author = "D. Niewerth and {van Meerloo}, J. and G. Jansen and Y.G. Assaraf and T.C. Hendrickx and C.J. Kirk and J.L. Anderl and S. Zweegman and G.J.L. Kaspers and J. Cloos",

year = "2014",

doi = "https://doi.org/10.1016/j.bcp.2014.02.005",

language = "Undefined/Unknown",

volume = "89",

pages = "43--51",

journal = "Biochemical Pharmacology",

issn = "0006-2952",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Anti-leukemic activity and mechanisms underlying resistance to the novel immunoproteasome inhibitor PR-924

AU - Niewerth, D.

AU - van Meerloo, J.

AU - Jansen, G.

AU - Assaraf, Y.G.

AU - Hendrickx, T.C.

AU - Kirk, C.J.

AU - Anderl, J.L.

AU - Zweegman, S.

AU - Kaspers, G.J.L.

AU - Cloos, J.

PY - 2014

Y1 - 2014

U2 - https://doi.org/10.1016/j.bcp.2014.02.005

DO - https://doi.org/10.1016/j.bcp.2014.02.005

M3 - Article

C2 - 24552657

SN - 0006-2952

VL - 89

SP - 43

EP - 51

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

IS - 1

ER -